Pulsenmore Ltd. (TLV:PLSM)
Israel
· Delayed Price · Currency is ILS · Price in ILA | Market Cap | 67.24M |
| Revenue (ttm) | 40.02M |
| Net Income (ttm) | -15.85M |
| Shares Out | 6.50M |
| EPS (ttm) | -2.46 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,155 |
| Average Volume | 14,985 |
| Open | 1,049.00 |
| Previous Close | 1,049.00 |
| Day's Range | 1,025.00 - 1,039.00 |
| 52-Week Range | 997.20 - 4,312.00 |
| Beta | 0.37 |
| RSI | 35.33 |
| Earnings Date | Mar 30, 2026 |
About Pulsenmore
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient’s smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel. [Read more]
Financial Performance
In 2025, Pulsenmore's revenue was 40.02 million, an increase of 314.28% compared to the previous year's 9.66 million. Losses were -15.85 million, -56.85% less than in 2024.
Financial StatementsNews
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
Management to Host Conference Call and Webcast today at 8:30am ET to Discuss Results and Provide Business Update OMER, Israel, March 30, 2026 /PRNewswire/ – Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM...
Pulsenmore Announces Full Year 2025 Earnings Conference Call
OMER, Israel, March 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it will release its financial results for full y...
Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance
OMER, Israel, Feb. 9, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a new commercial engagement with TLC Perinatal PA, a ma...
Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center
OMER, Israel, Feb. 2, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in ...
Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation
Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month pilot; Service to be deployed via Beilinson NEXT, Beilinson's virtual hospital RAMAT GAN, Israe...
Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
RAMAT GAN, Israel, Jan. 21, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that its shares will begin trading on Nasdaq at ...